Ontrak, Inc. operates as an artificial intelligence-powered, virtualized outpatient healthcare treatment company that provides in-person or telehealth intervention services to health plans and other third-party payors. Its Ontrak PRE (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behaviour change, recommends care pathways that people are willing to follow, and engages people who aren’t getting the care they need. The company’s technology-enabled, OnTrak, program is designed to treat health plan members with unaddressed behavioural health conditions that cause or exacerbate chronic medical diseases, such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was founded in 2003 and is headquartered in Santa Monica, California.
Currently trading at 67.79, 69.9% below fair value (fair value $224.92). Earnings are forecast to grow 72% per year and have returned 382.8% over the past year. Further upside is likely following a break above the Falling Wedge pattern (1).
Currently trading at 67.79, 69.9% below fair value (fair value $224.92). Earnings are forecast to grow 72% per year and have returned 382.8% over the past year. Further upside is likely following a break above the Falling Wedge pattern (1).